Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

15.4%

2 terminated out of 13 trials

Success Rate

83.3%

-3.2% vs benchmark

Late-Stage Pipeline

23%

3 trials in Phase 3/4

Results Transparency

20%

2 of 10 completed with results

Key Signals

2 with results83% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (9)
P 3 (1)
P 4 (2)

Trial Status

Completed10
Terminated2
Unknown1

Trial Success Rate

83.3%

Benchmark: 86.5%

Based on 10 completed trials

Clinical Trials (13)

Research Network

Activity Timeline